HCW Biologics Prices $1.6M Private Placement, Adding to Recent Capital Raises
HCWB sits 74% above its 52-week low of $1.5.
Summary
HCW Biologics priced a $1.6 million private placement, following a $4.0 million raise in May and a reverse stock split in June. The offering is modest relative to the company's $4.1 million market cap but continues a pattern of frequent, small-scale financings to fund operations amid a going concern warning. The company recently reported positive Phase 1 data for its alopecia drug and regained rights to two compounds, but cash runway remains tight. Terms of the new placement, including pricing and warrant coverage, were not disclosed.
At the time of this announcement, HCWB was trading at $2.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $1.50 to $44.10. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.